Published

The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuroscience Applied
Date: 2022-01-01
Source: OpenAlex
DOI: 10.1016/j.nsa.2022.100213
PubMed: Unavailable

Authors

G. Goodwin Scott T. Aaronson Boadie W. Dunlop D. Feifel David J. Hellerstein L. Marwood S. Mistry Metten Somers S.C. Stansfield J. Tsai S. Williams Allan H. Young Sidney Zisook E. Malievskaia

Watch author

Derived topics and classifications

psilocybin Depression Headache / Migraine Clinical Trial Randomized Controlled Trial Adolescents Treatment-Resistant Depression Safety Adverse Events Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial2022-01-01

Related papers

Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01 Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2020-01-01 S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-19 Med Check: Psilocybin for OCD, Nuplazid Vote, and MorePsychiatric News · 2022-08-01 Can Psilocybin Treat Severe DepressionJournal watch · 2017-11-03 Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)ClinicalTrials.gov · 2026-07-09 Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)ClinicalTrials.gov · 2025-10-07